Diagnostic Criteria for Human Disharmony Loop. by James M. Friedman (22522150)

Subjects:

Fig 6 - by Keith Fraser (1868587)

Subjects:

Summary of cell-based assay EC50 results for WT BMP9 and A347E variant. by Tobias G. Schips (21799838)

Subjects:

The Fibrosis scoring by Sirius Red staining and SHG/TPEF. by Xueqin lu (22250795)

Subjects:

Average proportion of first choice female applicants stratified by specialty category. by Lucy Hui (17538542)

Subjects:

Gender differences in first choice match outcomes. by Lucy Hui (17538542)

Subjects:

Total number of applications to each discipline grouped by (a) clinical disciplines, (b) diagnostic disciplines, and (c) surgical disciplines. by Lucy Hui (17538542)

Subjects:

Number of applicants matched to each discipline grouped by (a) clinical disciplines, (b) diagnostic disciplines, and (c) surgical disciplines. by Lucy Hui (17538542)

Subjects:

Fig 7 - by Keith Fraser (1868587)

Subjects:

Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

Subjects:

Trend components extracted from the X11 process for various types of viral hepatitis in Zhejiang Province from 2004 to 2023. by Ming Xue (591840)

Subjects:

Forest plot of the scaling exponent of hepatitis incidence from 2004 to 2023 (a. forest plot of hepatitis A; b. forest plot of hepatitis B; c. forest plot of hepatitis C; d. forest... by Ming Xue (591840)

Subjects:

Seasonal components extracted from the X11 process of various types of viral hepatitis in Zhejiang Province from 2004 to 2023. by Ming Xue (591840)

Subjects:

Database of the incidence rates of various types of viral hepatitis in Zhejiang Province from 2004 to 2023. by Ming Xue (591840)

Subjects:

Trends in the proportions of various types of viral hepatitis in Zhejiang Province from 2004 to 2023. by Ming Xue (591840)

Subjects:

Data Sheet 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Data Sheet 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Data Sheet 3_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Patient characteristics before and after propensity score matching. by Anna D. Ware (19688153)

Subjects:

An <i>In Situ</i> TEM Study of the Diffusivity of Gold Atoms in Nanocomposite Thin Films by Zirconia Co-Deposition: Implication for Neuromorphic Devices by Alberto Casu (1285227)

Subjects: